Sun Pharma arm gets relief from US court in patent infringement case

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said

Press Trust of India December 26, 2018 17:45:41 IST
Sun Pharma arm gets relief from US court in patent infringement case

New Delhi: Sun Pharma on Wednesday said its arm DUSA Pharmaceuticals has received relief from a US court in a patent infringement case.

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said in a regulatory filing.

Sun Pharma arm gets relief from US court in patent infringement case

Representational image. Reuters

Earlier this year, DUSA, which is wholly-owned by Sun Pharma, filed a lawsuit against the Biofrontera defendants in the US District Court for the District of Massachusetts.

The lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.

DUSA, in its amended complaint filed in July 2018, additionally alleged the Biofrontera defendants misappropriated confidential and trade secret information by obtaining confidential information from its former employees to sell and market defendants' own products.

The lawsuit sought an assessment of both damages and injunctive relief against the Biofrontera defendants, Sun Pharma said.

The court's order prohibits Biofrontera from making use of or disseminating DUSA's sales and financial information, customer lists and customer target lists, training and marketing materials, standard operating procedures, technical information, and unpublished clinical data, and any derivations thereof, effective immediately, it added.

Sun Pharma shares on Wednesday ended 2.23 percent down at Rs 414 apiece on the BSE.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Donald Trump is running the kind of presidential campaign he likes, but not one he needs
World

Donald Trump is running the kind of presidential campaign he likes, but not one he needs

Away from their candidate and the television cameras, some of Trump’s aides are quietly conceding just how dire his political predicament appears to be, and his inner circle has returned to a state of recriminations and backbiting

'I'll have to leave the country': Donald Trump, trailing in polls to Joe Biden, fights to gain ground in Florida and Georgia
World

'I'll have to leave the country': Donald Trump, trailing in polls to Joe Biden, fights to gain ground in Florida and Georgia

Calling Joe Biden 'the worst candidate in the history of presidential politics', Trump claimed the Democratic candidate would deliver communism and a flood of immigrants

US Election 2020 Highlights: Joe Biden pips Donald Trump overall as duelling town halls come to a close
World

US Election 2020 Highlights: Joe Biden pips Donald Trump overall as duelling town halls come to a close

US Election 2020 LIVE Updates: Joe Biden vowed for the first time to come out with a clear position before Election Day on whether he supported expanding the size of the Supreme Court